HUMAN ANTI-TAU ANTIBODIES

Provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for tau are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments,...

Full description

Saved in:
Bibliographic Details
Main Authors MONTRASIO, FABIO, WEINREB, PAUL H, CHEN, FENG, GARBER, ELLEN A, GRIMM, JAN
Format Patent
LanguageEnglish
French
Published 26.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for tau are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for tau targeted immunotherapy and diagnosis, respectively. L'invention concerne de nouveaux anticorps humains spécifiques de tau ainsi que des fragments, dérivés et variants associés, ainsi que des procédés associés. L'invention concerne également des dosages, des kits et des supports solides associés aux anticorps spécifiques de tau. L'anticorps, la ou les chaînes d'immunoglobuline, ainsi que les fragments de liaison, dérivés et variants associés, peuvent être utilisés dans des compositions pharmaceutiques et de diagnostic pour l'immunothérapie et le diagnostic ciblés de tau, respectivement.
AbstractList Provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for tau are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for tau targeted immunotherapy and diagnosis, respectively. L'invention concerne de nouveaux anticorps humains spécifiques de tau ainsi que des fragments, dérivés et variants associés, ainsi que des procédés associés. L'invention concerne également des dosages, des kits et des supports solides associés aux anticorps spécifiques de tau. L'anticorps, la ou les chaînes d'immunoglobuline, ainsi que les fragments de liaison, dérivés et variants associés, peuvent être utilisés dans des compositions pharmaceutiques et de diagnostic pour l'immunothérapie et le diagnostic ciblés de tau, respectivement.
Author WEINREB, PAUL H
CHEN, FENG
MONTRASIO, FABIO
GARBER, ELLEN A
GRIMM, JAN
Author_xml – fullname: MONTRASIO, FABIO
– fullname: WEINREB, PAUL H
– fullname: CHEN, FENG
– fullname: GARBER, ELLEN A
– fullname: GRIMM, JAN
BookMark eNrjYmDJy89L5WSQ9Aj1dfRTcPQL8dQNcQwFM5z8XTxdg3kYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyzo5GFpZmBmZmjoTERSgCVhCEs
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ANTICORPS ANTI-TAU HUMAINS
ExternalDocumentID CA2896066A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2896066A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:24:03 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2896066A13
Notes Application Number: CA20132896066
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&CC=CA&NR=2896066A1
ParticipantIDs epo_espacenet_CA2896066A1
PublicationCentury 2000
PublicationDate 20140626
PublicationDateYYYYMMDD 2014-06-26
PublicationDate_xml – month: 06
  year: 2014
  text: 20140626
  day: 26
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies BIOGEN MA INC
BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
RelatedCompanies_xml – name: BIOGEN MA INC
– name: BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
Score 2.9398937
Snippet Provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HUMAN ANTI-TAU ANTIBODIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&locale=&CC=CA&NR=2896066A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFPVNp2L9RR-kb0XWdp19KJKmLVVoO6SVvY0kbWAv23AV_30voZu-6FtI4JIcXL77krsLwAMTLJjyZmI3TDLb8zm3g0C6tvBFMOEuG0td1Ccv_Kz2XueT-QCWu1wYXSf0SxdHRIsSaO-dPq83P5dYsY6t3D7yJXatn9MqjK2eHSNbQAfdiqMwmZVxSS1KQ0qs4i1EXqFcdYJE6QC96KkyhuQ9Ukkpm9-Ikp7C4QyFrbozGLSrERzT3cdrIzjK-_dubPamtz0HI6tzUpikqF7sitS6EZXKm7sAM00qmtk4x2K_nwUl-9W4lzBEmt9egakKHT8FCCSuI71xI5lw3UYKx2sRQhBJDTD-FHP9z9gNnCjFqPAmx7-FYffx2d4hkHb8XqvgG2sndHk
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsX52QfpW5H1a_ahSJq2dLq2Q1rZW0k_AnvZhqv473sJ3fRF30ICl-Tg8rtfcncBeGAVcyZlbWk140wz7bLUHIcbWmVXjlUabMxlUZ84saPcfFlYix4sd7kwsk7olyyOiBZVob238rze_Fxi-TK2cvtYLrFr_Rxmrq927BjZAjroqu-5wTz1U6pS6lKiJm8u8grhqhMkSgfoYU-EMQTvnkhK2fxGlPAEDucobNWeQq9ZDWFAdx-vDeEo7t67sdmZ3vYMRlEek0QhSTbVMpLLhpcKb-4clDDIaKThHMV-PwUl-9UYF9BHmt9cgiIKHT85CCSGzs1xzVllGDWvdLNBCEEkHcHoTzFX_4zdwyDK4lkxmyav13AslCRCnXT7Bvrtx2dzi6DalndSHd8Lmnds
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HUMAN+ANTI-TAU+ANTIBODIES&rft.inventor=MONTRASIO%2C+FABIO&rft.inventor=WEINREB%2C+PAUL+H&rft.inventor=CHEN%2C+FENG&rft.inventor=GARBER%2C+ELLEN+A&rft.inventor=GRIMM%2C+JAN&rft.date=2014-06-26&rft.externalDBID=A1&rft.externalDocID=CA2896066A1